SCHEMBL17385992

SCHEMBL17385992

COC(=O)c1ccc(/C=C/Cc2cc(C)cc(OC)c2)c(Br)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOTUM Q6P988 1/20 0.42
▸ CA1 P00915 2/20 0.38
▸ CA2 P00918 2/20 0.38
▸ ALDH1A1 P00352 4/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ P4HB P07237 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ LMNA P02545 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ CCR6 P51684 1/20 0.36
▸ HKDC1 Q2TB90 1/20 0.36
▸ KDM1A O60341 1/20 0.36
▸ MAPK10 P53779 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17385993 1.00 NOTUM (0.42) NOTUMCA1CA2ALDH1A1KDM4E
SCHEMBL17429650 0.92 NOTUM (0.47) NOTUMCA1CA2ALDH1A1KDM4E
SCHEMBL17386254 0.86 LMNA (0.45) NOTUMALDH1A1P4HBNPC1LMNA
SCHEMBL17386255 0.86 LMNA (0.45) NOTUMALDH1A1P4HBNPC1LMNA
SCHEMBL17429644 0.85 NOTUM (0.45) NOTUMALDH1A1KDM4EP4HBTDP1
SCHEMBL17386142 0.80 NPC1 (0.39) ALDH1A1KDM4ENPC1LMNAMAPT
SCHEMBL17386143 0.80 NPC1 (0.39) ALDH1A1KDM4ENPC1LMNAMAPT
SCHEMBL17386083 0.76 P4HB (0.43) NOTUMCA1CA2ALDH1A1KDM4E
SCHEMBL17386038 0.75 ALDH1A1 (0.41) NOTUMCA1CA2ALDH1A1KDM4E
SCHEMBL17386226 0.72 CA1 (0.53) CA1CA2ALDH1A1TDP1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2963027-B1 TRICYCLIC COMPOUND AND USE THEREOF TIUMBIO CO LTD (KR) 2018-12-26 — — EP disclosed
US-9643946-B2 Tricyclic compound and use thereof SK CHEMICALS CO., LTD. (KR) 2017-05-09 — — US disclosed
US-9643946-B2 Tricyclic compound and use thereof SK CHEMICALS CO., LTD. (KR) 2017-05-09 — — US disclosed
US-20160009677-A1 TRICYCLIC COMPOUND AND USE THEREOF SK CHEMICALS CO., LTD. (KR) 2016-01-14 — — US disclosed
US-20160009677-A1 TRICYCLIC COMPOUND AND USE THEREOF SK CHEMICALS CO., LTD. (KR) 2016-01-14 — — US disclosed
EP-2963027-A1 TRICYCLIC COMPOUND AND USE THEREOF SK Chemicals Co., Ltd. (KR) 2016-01-06 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160009677-A1 TRICYCLIC COMPOUND AND USE THEREOF GPR65, GPR119, GPR35 NOTUM 1257/4885CA1 2727/4885CA2 1252/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback